All In Biotech

Free tool

FAERS Monitor: Ciprodex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021537 or its brand name (Ciprodex, Ciprofloxacin, Dexamethasone). Reports on generic versions are filed under their own applications.

Reports

77

Serious

33

43% of reports

Hospitalization

21

Death reported

0

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective11
  • fatigue7
  • product dose omission issue7
  • dizziness5
  • dyspnoea5
  • headache5
  • inappropriate schedule of product administration4
  • nausea4
  • neck pain4
  • paraesthesia4
  • pneumonia4
  • product quality issue4
  • product use in unapproved indication4
  • pyrexia4
  • vomiting4

Reports by year received

View as table
YearReports
20141
20202
20215
20228
202311
202411
202531
20268

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,082 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
neck painSignal419.67.553
product quality issueSignal48.03.118
paraesthesiaSignal46.92.715
product dose omission issueSignal76.53.228
inappropriate schedule of product administrationSignal46.12.312
product use in unapproved indicationSignal44.41.77
pneumoniaSignal43.41.35
pyrexiaSignal43.21.24
dizzinessSignal52.71.24
fatigueSignal72.51.25
dyspnoea52.41.03
vomiting42.30.92
drug ineffectiveSignal112.31.37
headache52.20.92
nausea41.40.50

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.